GLP-2T Certificate of Analysis Results
What the GLP-2T record shows
Evidence through 2026-03-31TitrateLab tracks 8 published GLP-2T certificate-of-analysis records through 2026-03-31. Across 8 records with a usable peptide-purity result, the median reported purity is 99.8%. Across 8 records with measured-versus-label dose data, 88% are within 10% of the labeled quantity. This is a public convenience sample, not a randomized market survey; one result describes one submitted sample and does not verify other batches.
Limits and missing evidence
- No classifiable endotoxin results were recorded.
- Coverage depends on reports that were published and available to ingest.
GLP-2T lab-testing metrics
COAs per testing lab
Every lab testing GLP-2T in the corpus.
Tested-purity distribution
Bins below 90% tested purity (0% of certs).
| Purity range | Certificates |
|---|---|
| 0–50% | 0 |
| 50–70% | 0 |
| 70–80% | 0 |
| 80–85% | 0 |
| 85–90% | 0 |
| 90–91% | 0 |
| 91–92% | 0 |
| 92–93% | 0 |
| 93–94% | 0 |
| 94–95% | 0 |
| 95–96% | 0 |
| 96–97% | 0 |
| 97–98% | 0 |
| 98–99% | 0 |
| 99–100% | 8 |
COAs over time
GLP-2T certificates published per month.
| Month | Certificates |
|---|---|
| 2025-10 | 1 |
| 2026-03 | 7 |
Most-tested vendors
Vendors by GLP-2T certificate count.
See who tests most — unlock the vendor names with Pro.
Published GLP-2T certificates of analysis
8 records. Zero guesswork.
Unlock the actual vendor, purity, dose accuracy, lab, batch and saved certificate for every GLP-2T result.
Sign in to viewIllustrative structure only. No record-level values are present in this preview.